抗药性的生化机制。IV. 白血病小鼠对5-氮杂胞苷产生抗药性及嘧啶代谢同时受抑制的发展过程 - Suppr

Suppr

超能文献

Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice.

作者信息

Veselý J, Cihák A, Sorm F

出版信息

Int J Cancer. 1967 Nov 15;2(6):639-46. doi: 10.1002/ijc.2910020625.

DOI:10.1002/ijc.2910020625

PMID:5582283

Abstract

摘要

相似文献

Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice.抗药性的生化机制。IV. 白血病小鼠对5-氮杂胞苷产生抗药性及嘧啶代谢同时受抑制的发展过程

Int J Cancer. 1967 Nov 15;2(6):639-46. doi: 10.1002/ijc.2910020625.

Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine.耐药性的生化机制。VII. 5-氮杂胞苷对5-氮杂胞苷敏感和耐药白血病小鼠乳清酸代谢的抑制作用

Biochem Pharmacol. 1968 Apr;17(4):519-24. doi: 10.1016/0006-2952(68)90267-0.

Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine.对5-氮杂胞苷和5-氮杂-2'-脱氧胞苷耐药的小鼠白血病细胞的特征

Cancer Res. 1968 Oct;28(10):1995-2000.

Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine.将5-氮杂胞苷掺入对5-氮杂胞苷敏感和耐药的白血病小鼠的肝脏核糖核酸中。

Biochim Biophys Acta. 1965 Nov 8;108(3):516-8. doi: 10.1016/0005-2787(65)90046-8.

Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.

Cancer Res. 1982 Mar;42(3):956-64.

Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects.人体嘧啶代谢。V. 动物和人类受试者体内抗肿瘤药物生化效应的测定

J Clin Invest. 1962 Apr;41(4):871-83. doi: 10.1172/JCI104544.

Regulatory mechanisms linked with RNA synthesis of avian leukaemic myeloblasts. I. Changes in the activity of pyrimidine ribonucleoside kinases.与禽白血病成髓细胞RNA合成相关的调节机制。I.嘧啶核糖核苷激酶活性的变化

Neoplasma. 1966;13(4):391-402.

5-Azacytidine, a new, highly effective cancerostatic.

Experientia. 1964 Apr 15;20(4):202-3. doi: 10.1007/BF02135399.

[Clinical pharmacology of anticancer agents (Part 4). Antimetabolites (1)].[抗癌药物的临床药理学（第4部分）。抗代谢物（1）]

Gan To Kagaku Ryoho. 1992 Feb;19(2):265-76.

OXONATE AND OTHER RELATED ANTIMETABOLITES OF THE SYNTHESIS DE NOVO OF PYRIMIDINE NUCLEOTIDES.嘧啶核苷酸从头合成的氧嗪酸盐及其他相关抗代谢物。

Acta Unio Int Contra Cancrum. 1964;20:1051-3.

引用本文的文献

Therapy with azanucleosides for myelodysplastic syndromes.治疗骨髓增生异常综合征的氮杂核苷类药物。

Nat Rev Clin Oncol. 2010 Aug;7(8):433-44. doi: 10.1038/nrclinonc.2010.87. Epub 2010 Jun 15.

DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells.C3H 10T1/2 C18细胞的5-氮杂-2'-脱氧胞苷抗性变体中的DNA甲基化

Mol Cell Biol. 1984 Oct;4(10):2098-102. doi: 10.1128/mcb.4.10.2098-2102.1984.

Effect of 5-azacytidine on developing mouse embryo.

Experientia. 1968 May 15;24(5):487-8. doi: 10.1007/BF02144408.

High-frequency induction in vivo of mouse leukemia in AKR strain by 5-azacytidine and 5-iodo-2'-deoxyuridine.

Experientia. 1973 Sep 15;29(9):1132-3. doi: 10.1007/BF01946763.

Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.核蛋白与含5-氮杂胞嘧啶的DNA的差异性结合作为5-氮杂-2'-脱氧胞苷耐药性的潜在机制。

Mol Cell Biol. 1987 Sep;7(9):3076-83. doi: 10.1128/mcb.7.9.3076-3083.1987.

3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.3-去氮尿苷（NSC 126849）：一种有趣的生化反应调节剂。

Invest New Drugs. 1986;4(1):67-84. doi: 10.1007/BF00172020.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验